logo

PBM

Psyence BiomedicalยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

PBM Profile

Psyence Biomedical Ltd.

A life sciences biotechnology company focusing on natural psychedelics

Pharmaceutical
06/29/2023
12/10/2021
NASDAQ Stock Exchange
12
03-31
Common stock
121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1
--
Psyence Biomedical Ltd. was incorporated as a company under the laws of Ontario, Canada on June 29, 2023. The company is a life science biotechnology company focused on natural hallucinogens. The Psyence Biomed division works with natural psilocybin products to heal psychological trauma and its mental health consequences in the context of palliative care. The company is committed to the development of advanced natural psilocybin products for clinical research and development. The company's main divisions, Psyence Production, Psyence Therapeutics and Psyence Function, operate in Canada, the United Kingdom, Southern Africa, Australia and the United States.